Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review
Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Atrion Corp (Atrion) develops and manufactures fluid delivery, cardiovascular, ophthalmic, and other medical and non-medical products. The company’s portfolio spans proprietary valves, silicone vessel loops, myocardial protection system, inflation devices, medical devices that disinfect contact lenses, balloon catheters, and products used in heart bypass surgery. Atrion also offers products for safe needle and scalpel blade containment, instrumentation and related disposables for measuring the clotting time of blood, inflation systems and valves for aviation and marine safety products, one-way and two-way pressure relief valves, and components used in inflatable survival products and structures. It sells its products to physicians, clinics, hospitals, and other treatment centers. It has direct operations in Delaware, Texas, and Alabama. Atrion is headquartered in Allen, Texas, the US.
Atrion Corp Key Recent Developments
Feb 26,2021: Atrion reports results for fourth quarter and full year 2020
Nov 09,2020: Atrion Reports Third Quarter Results 2020
Aug 06,2020: Atrion reports second quarter results
May 07,2020: Atrion reports first quarter results
Feb 26,2020: Atrion reports results for fourth quarter and full year 2019
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Atrion Corp (Atrion) develops and manufactures fluid delivery, cardiovascular, ophthalmic, and other medical and non-medical products. The company’s portfolio spans proprietary valves, silicone vessel loops, myocardial protection system, inflation devices, medical devices that disinfect contact lenses, balloon catheters, and products used in heart bypass surgery. Atrion also offers products for safe needle and scalpel blade containment, instrumentation and related disposables for measuring the clotting time of blood, inflation systems and valves for aviation and marine safety products, one-way and two-way pressure relief valves, and components used in inflatable survival products and structures. It sells its products to physicians, clinics, hospitals, and other treatment centers. It has direct operations in Delaware, Texas, and Alabama. Atrion is headquartered in Allen, Texas, the US.
Atrion Corp Key Recent Developments
Feb 26,2021: Atrion reports results for fourth quarter and full year 2020
Nov 09,2020: Atrion Reports Third Quarter Results 2020
Aug 06,2020: Atrion reports second quarter results
May 07,2020: Atrion reports first quarter results
Feb 26,2020: Atrion reports results for fourth quarter and full year 2019
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Atrion Corp - Key Facts
Atrion Corp - Key Employees
Atrion Corp - Key Employee Biographies
Atrion Corp - Major Products and Services
Atrion Corp - History
Atrion Corp - Company Statement
Atrion Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Atrion Corp - Business Description
Product Category: Cardiovascular
Overview
Performance
Product Category: Fluid Delivery
Overview
Performance
Product Category: Ophthalmology
Overview
Performance
Product Category: Other
Overview
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Other Countries Less than 5% of Revenue
Performance
Geographical Segment: The US
Performance
Atrion Corp - Corporate Strategy
Atrion Corp - SWOT Analysis
SWOT Analysis - Overview
Atrion Corp - Strengths
Atrion Corp - Weaknesses
Atrion Corp - Opportunities
Atrion Corp - Threats
Atrion Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Feb 26, 2021: Atrion reports results for fourth quarter and full year 2020
Nov 09, 2020: Atrion Reports Third Quarter Results 2020
Aug 06, 2020: Atrion reports second quarter results
May 07, 2020: Atrion reports first quarter results
Feb 26, 2020: Atrion reports results for fourth quarter and full year 2019
SECTION 5 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Atrion Corp - Key Facts
Atrion Corp - Key Employees
Atrion Corp - Key Employee Biographies
Atrion Corp - Major Products and Services
Atrion Corp - History
Atrion Corp - Company Statement
Atrion Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Atrion Corp - Business Description
Product Category: Cardiovascular
Overview
Performance
Product Category: Fluid Delivery
Overview
Performance
Product Category: Ophthalmology
Overview
Performance
Product Category: Other
Overview
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Other Countries Less than 5% of Revenue
Performance
Geographical Segment: The US
Performance
Atrion Corp - Corporate Strategy
Atrion Corp - SWOT Analysis
SWOT Analysis - Overview
Atrion Corp - Strengths
Atrion Corp - Weaknesses
Atrion Corp - Opportunities
Atrion Corp - Threats
Atrion Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Feb 26, 2021: Atrion reports results for fourth quarter and full year 2020
Nov 09, 2020: Atrion Reports Third Quarter Results 2020
Aug 06, 2020: Atrion reports second quarter results
May 07, 2020: Atrion reports first quarter results
Feb 26, 2020: Atrion reports results for fourth quarter and full year 2019
SECTION 5 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Atrion Corp, Key Facts
Atrion Corp, Key Employees
Atrion Corp, Key Employee Biographies
Atrion Corp, Major Products and Services
Atrion Corp, History
Atrion Corp, Subsidiaries
Atrion Corp, Key Competitors
Atrion Corp, Ratios based on current share price
Atrion Corp, Annual Ratios
Atrion Corp, Annual Ratios (Cont...1)
Atrion Corp, Annual Ratios (Cont...2)
Atrion Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Atrion Corp, Key Facts
Atrion Corp, Key Employees
Atrion Corp, Key Employee Biographies
Atrion Corp, Major Products and Services
Atrion Corp, History
Atrion Corp, Subsidiaries
Atrion Corp, Key Competitors
Atrion Corp, Ratios based on current share price
Atrion Corp, Annual Ratios
Atrion Corp, Annual Ratios (Cont...1)
Atrion Corp, Annual Ratios (Cont...2)
Atrion Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Atrion Corp, Performance Chart (2016 - 2020)
Atrion Corp, Ratio Charts
Atrion Corp, Performance Chart (2016 - 2020)
Atrion Corp, Ratio Charts